Predicting pulmonary fibrosis disease course from past trends in pulmonary function. (Q30407660)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

title

Predicting pulmonary fibrosis disease course from past trends in pulmonary function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

9

Fernando J Martinez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

3

Meilan K Han

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

2

Nabihah Tayob

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

7

Athol U Wells

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

10

Kevin R Flaherty

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

5

Dolly Kervitsky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Shelley L Schmidt

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

Christopher Zappala

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

Kevin K Brown

series ordinal

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

1 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

volume

145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

579-585

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

Idiopathic pulmonary fibrosis: lung function is a clinically meaningful endpoint for phase III trials

29 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Pirfenidone in idiopathic pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

High-dose acetylcysteine in idiopathic pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Radiological versus histological diagnosis in UIP and NSIP: survival implications.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Clinical significance of histological classification of idiopathic interstitial pneumonia

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941249

Prognostic Value of Desaturation during a 6-Minute Walk Test in Idiopathic Interstitial Pneumonia

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24231810

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24231810

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24231810

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1378/CHEST.13-0844

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24231810 AND SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

24231810

1 reference